Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

It is a mistake to claim that there is not widespread research into the effectiveness of vaccines, especially those given to ...

The CDC's newly reconstituted Advisory Committee on Immunization Practices (ACIP) voted 5-2 in support of infants younger ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

Discover how Professor Shabir Madhi is advancing maternal vaccines to safeguard newborns from RSV, GBS, and more.

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

CDC panel backs Merck's Enflonsia for RSV prevention in infants; FDA-approved therapy reduced hospitalizations by 84% in ...

A group of mothers in Victoria say they've experienced trouble accessing the jab for a highly infectious illness that infects ...

Robert F. Kennedy Jr.’s vaccine advisory committee recommended Merck & Co.’s shot to prevent newborns from getting RSV, ...

While respiratory syncytial virus (RSV) typically causes mild symptoms in adults, the virus can be life-threatening for infants. The seasonal virus is the most common cause of lower respiratory tract ...